ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

PA Center To Receive Share Of State’s Tobacco Settlement.

September 7, 2001

ACS’ Freeman; Declare New War In Cancer; Poor Get Substandard Treatment, Lost Dignity

July 21, 1989